BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24391068)

  • 1. The influence of selected factors on the attendance of the high-risk population in the early lung cancer detection program.
    Zakrzewska A; Szczepanowska M; Książek J; Biadacz I; Dziedzic R; Jelitto-Górska M; Rzyman W
    Pneumonol Alergol Pol; 2014; 82(1):25-31. PubMed ID: 24391068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective use of low-dose computed tomography lung cancer screening.
    Jeffers CD; Pandey T; Jambhekar K; Meek M
    Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.
    Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI
    Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography screening for lung cancer: a survey of society of thoracic radiology members.
    Eberth JM; Qiu R; Linder SK; Gallant NR; Munden RF
    J Thorac Imaging; 2014 Sep; 29(5):289-92. PubMed ID: 25100140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
    Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
    Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
    Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
    Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should you be screened for lung cancer?
    Johns Hopkins Med Lett Health After 50; 2013 Nov; 25(11):1-2. PubMed ID: 24634953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application value of low-dose computed tomography for the screening of lung cancer in high-risk group].
    Lei Y; Chen BJ; Zeng L; Li WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):584-7. PubMed ID: 22997901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].
    Wen Y; Yu LZ; Du LB; Wei DH; Liu YY; Yang ZY; Zheng YD; Wu Z; Yu XY; Zhao L; Yu YW; Chen HD; Ren JS; Qin C; Xu YJ; Cao W; Wang F; Li J; Tan FW; Dai M; Chen WQ; Li N; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):633-639. PubMed ID: 34034404
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China.
    Guo LW; Chen Q; Shen YC; Meng QC; Zheng LY; Wu Y; Cao XQ; Xu HF; Liu SZ; Sun XB; Qiao YL; Zhang SK
    JAMA Netw Open; 2020 Nov; 3(11):e2019039. PubMed ID: 33141158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Community Perspectives for a Lung Cancer Screening Awareness Campaign in Appalachia Kentucky: The Terminate Lung Cancer (TLC) Study.
    Cardarelli R; Roper KL; Cardarelli K; Feltner FJ; Prater S; Ledford KM; Justice B; Reese DR; Wagner P; Cantrell C
    J Cancer Educ; 2017 Mar; 32(1):125-134. PubMed ID: 26411308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary experiences with low-dose computed tomography for lung cancer screening in Hungary].
    Moizs M; Bajzik G; Lelovics Z; Rakvács M; Strausz J; Repa I
    Orv Hetil; 2014 Mar; 155(10):383-8. PubMed ID: 24583559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Queensland Lung Cancer Screening Study: rationale, design and methods.
    Marshall HM; Bowman RV; Crossin J; Lau MA; Slaughter RE; Passmore LH; McCaul EM; Courtney DA; Windsor MN; Yang IA; Smith IR; Keir BJ; Hayes TJ; Redmond SJ; Zimmerman PV; Fong KM
    Intern Med J; 2013 Feb; 43(2):174-82. PubMed ID: 22471951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Outcomes of a Lung Cancer Screening Program in an Integrated Community Health System.
    Miller AT; Kruger P; Conner K; Robertson T; Rowley B; Sause W; Ruckdeschel JC; Blagev DP
    J Am Coll Radiol; 2016 Jun; 13(6):733-7. PubMed ID: 27131618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
    Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
    BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of an Integrated Lung Cancer Prevention and Screening Program Using a Mobile Computed Tomography (CT) Unit in Brazil.
    Chiarantano RS; Vazquez FL; Franco A; Ferreira LC; Cristina da Costa M; Talarico T; Oliveira ÂN; Miziara JE; Mauad EC; Caetano da Silva E; Ventura LM; Junior RH; Leal LF; Reis RM
    Cancer Control; 2022; 29():10732748221121385. PubMed ID: 36204992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk community and primary care providers knowledge about and barriers to low-dose computed topography lung cancer screening.
    Simmons VN; Gray JE; Schabath MB; Wilson LE; Quinn GP
    Lung Cancer; 2017 Apr; 106():42-49. PubMed ID: 28285693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.